Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10703777 | 0.79 | — | — | |
| SCHEMBL8469715 | 0.77 | — | — | |
| SCHEMBL1936734 | 0.72 | — | — | |
| SCHEMBL465939 | 0.72 | — | — | |
| SCHEMBL6537398 | 0.72 | — | — | |
| SCHEMBL17188621 | 0.72 | — | — | |
| SCHEMBL18536 | 0.72 | — | — | |
| SCHEMBL1936731 | 0.72 | — | — | |
| SCHEMBL11218749 | 0.71 | ALDH1A1 (0.47) | ALDH1A1CYP2D6ALOX15TSHR | |
| SCHEMBL13739882 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 155 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160158261-A1 | Antibiotic Kit and Composition and Uses Thereof | FOAMIX LTD. (IL) | 2016-06-09 | — | — | US | claimed |
| US-9211259-B2 | Antibiotic kit and composition and uses thereof | FOAMIX PHARMACEUTICALS LTD. (IL) | 2015-12-15 | — | — | US | claimed |
| EP-1919449-A2 | ANTIBIOTIC KIT AND COMPOSITION AND USES THEREOF | Foamix Ltd. (IL) | 2008-05-14 | — | — | EP | claimed |
| WO-2007099396-A2 | ANTIBIOTIC KIT AND COMPOSITION AND USES THEREOF | FOAMIX LTD. (US) | 2007-09-07 | — | — | WO | claimed |
| US-20060269485-A1 | Antibiotic kit and composition and uses thereof | FOAMIX LTD. (IL) | 2006-11-30 | — | — | US | claimed |
| EP-4674476-A1 | MAGNETIC FIELD VARIATION THERAPY FOR ENHANCING THERAPEUTIC AND DISINFECTION APPLICATIONS | Azyro SA (LU) | 2026-01-07 | — | — | EP | disclosed |
| EP-3802850-B1 | DEVICES AND SYSTEMS FOR GASTROINTESTINAL MICROBIOME DETECTION AND MANIPULATION | BT BIDCO INC (US) | 2025-11-19 | — | — | EP | disclosed |
| US-20250082265-A1 | TREATMENT OF A DISEASE OF THE GASTROINTESTINAL TRACT WITH AN IMMUNOSUPPRESSANT | BT BIDCO, INC. | 2025-03-13 | — | — | US | disclosed |
| US-20250000364-A1 | GASTROINTESTINAL TRACT DETECTION METHODS, DEVICES AND SYSTEMS | GLAS USA LLC | 2025-01-02 | — | — | US | disclosed |
| US-12150775-B2 | Treatment of a disease of the gastrointestinal tract with an immunosuppressant | BIORA THERAPEUTICS, INC. (US) | 2024-11-26 | — | — | US | disclosed |
| CN-118873822-A | Treatment of gastrointestinal disorders with TNF inhibitors | 比奥拉治疗股份有限公司 | 2024-11-01 | — | — | CN | disclosed |
| US-20240335644-A1 | TREATMENT OF A DISEASE OF THE GASTROINTESTINAL TRACT WITH AN IMMUNE MODULATORY AGENT RELEASED USING AN INGESTIBLE DEVICE | GLAS USA LLC | 2024-10-10 | — | — | US | disclosed |
| US-20080206161-A1 | QUIESCENT FOAMABLE COMPOSITIONS, STEROIDS, KITS AND USES THEREOF | FOAMIX PHARMACEUTICALS LTD. (IL) | 2008-08-28 | — | — | US | disclosed |
| WO-2008075207-A2 | ANTI-INFECTION AUGMENTATION FOAMABLE COMPOSITIONS AND KIT AND USES THEREOF | FOAMIX LTD. (US) | 2008-06-26 | — | — | WO | disclosed |
| EP-1919449-A2 | ANTIBIOTIC KIT AND COMPOSITION AND USES THEREOF | Foamix Ltd. (IL) | 2008-05-14 | — | — | EP | disclosed |
| US-20080063607-A1 | Oleaginous pharmaceutical and cosmetic foam | FOAMIX LTD | 2008-03-13 | — | — | US | disclosed |
| US-20070292461-A1 | Oleaginous pharmaceutical and cosmetic foam | FOAMIX LTD. (IL) | 2007-12-20 | — | — | US | disclosed |
| US-20070292355-A1 | Anti-infection augmentation foamable compositions and kit and uses thereof | FOAMIX LTD. | 2007-12-20 | — | — | US | disclosed |
| WO-2007099396-A2 | ANTIBIOTIC KIT AND COMPOSITION AND USES THEREOF | FOAMIX LTD. (US) | 2007-09-07 | — | — | WO | disclosed |
| US-20060269485-A1 | Antibiotic kit and composition and uses thereof | FOAMIX LTD. (IL) | 2006-11-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080206161-A1 | QUIESCENT FOAMABLE COMPOSITIONS, STEROIDS, KITS AND USES THEREOF | NR5A1, CYP17A1, LIPA | ALDH1A1 1705/4885CYP2D6 3081/4885ALOX15 232/4885 |
| US-20070292461-A1 | Oleaginous pharmaceutical and cosmetic foam | LIPA, LIPC, PLIN3 | ALDH1A1 2577/4885CYP2D6 2614/4885ALOX15 76/4885 |
| US-20070292355-A1 | Anti-infection augmentation foamable compositions and kit and uses thereof | CUTA, KIT, PRF1 | ALDH1A1 2540/4885CYP2D6 4376/4885ALOX15 1998/4885 |
| US-20250082265-A1 | TREATMENT OF A DISEASE OF THE GASTROINTESTINAL TRACT WITH AN IMMUNOSUPPRESSANT | TPMT, FABP2, SLC10A2 | ALDH1A1 2956/4885CYP2D6 732/4885ALOX15 307/4885 |
| US-20240335644-A1 | TREATMENT OF A DISEASE OF THE GASTROINTESTINAL TRACT WITH AN IMMUNE MODULATORY AGENT RELEASED USING AN INGESTIBLE DEVICE | CD40LG, CD40, ICOS | ALDH1A1 3879/4885CYP2D6 2638/4885ALOX15 154/4885 |
| US-20250000364-A1 | GASTROINTESTINAL TRACT DETECTION METHODS, DEVICES AND SYSTEMS | FABP2, SI, MLNR | ALDH1A1 2760/4885CYP2D6 288/4885ALOX15 2672/4885 |
| US-20080063607-A1 | Oleaginous pharmaceutical and cosmetic foam | LIPA, LIPC, PLIN3 | ALDH1A1 2577/4885CYP2D6 2614/4885ALOX15 76/4885 |
| US-12150775-B2 | Treatment of a disease of the gastrointestinal tract with an immunosuppressant | TPMT, FABP2, SLC10A2 | ALDH1A1 2956/4885CYP2D6 732/4885ALOX15 307/4885 |
| US-20160158261-A1 | Antibiotic Kit and Composition and Uses Thereof | KIT, RAB5IF, CUTA | ALDH1A1 1257/4885CYP2D6 2736/4885ALOX15 3394/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.